Currently, there has been some progress in using lysine specific demethylase 1 (LSD1) inhibitors as a pharmacological blockage of EWS-FLI function, and this could be an attractive therapeutic strategy for Ewing sarcoma/primitive neuroectodermal tumor47. This evidence concerns the gene FLII and Ewing sarcoma.